ChemoCentryx
CCXI
#3654
Rank
HK$29.33 B
Marketcap
HK$407.90
Share price
0.00%
Change (1 day)
34.95%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: HK$29.33 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.33 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.263 T 17,843.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.273 T 4,239.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$4.060 T 13,742.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.943 T 6,524.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$290.85 B 891.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.773 T 9,352.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$983.88 B 3,253.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$774.37 B 2,539.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$390.16 B 1,230.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel